Age defining immune effector cell associated neurotoxicity syndromes in aggressive large B cell lymphoma patients treated with axicabtagene ciloleucel

Am J Hematol. 2021 Nov 1;96(11):E427-E430. doi: 10.1002/ajh.26330. Epub 2021 Sep 7.

Authors

Affiliations

¹ Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
² Division of Hematology and Research Unit in Translational Hematology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
³ Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.

PMID: 34424554
DOI: 10.1002/ajh.26330

No abstract available

Publication types

Letter

MeSH terms

Adult
Age Factors
Aged
Agraphia / etiology
Antineoplastic Agents, Immunological / adverse effects*
Antineoplastic Agents, Immunological / therapeutic use
Aphasia / etiology
Biological Products / adverse effects*
Biological Products / therapeutic use
Confusion / etiology
Humans
Immunotherapy, Adoptive / adverse effects*
Lymphoma, Large B-Cell, Diffuse / therapy*
Middle Aged
Neurotoxicity Syndromes / etiology*
Retrospective Studies

Substances

Antineoplastic Agents, Immunological
Biological Products
axicabtagene ciloleucel